Ucb Biopharma Srl

This study tests a new medicine called galvokimig for adults with moderate-to-severe eczema (atopic dermatitis). About 160 participants will receive either different doses of the drug or a placebo to see how well it clears skin and reduces itching. The main goal is to find the be…

This study tests a drug called rozanolixizumab in 12 children aged 2 to 17 with moderate to severe generalized myasthenia gravis, a disease that causes muscle weakness. The main goal is to check the drug's safety and side effects. Participants receive the drug as a shot under the…

This study tests a drug called bimekizumab in children aged 2 to 17 with certain types of juvenile arthritis (enthesitis-related arthritis and juvenile psoriatic arthritis). The goal is to see how the drug moves through the body and if it is safe. About 40 children will receive t…

This study tests a drug called rozanolixizumab in 40 Chinese adults with generalized myasthenia gravis, a condition causing muscle weakness. The main goal is to see if the drug improves daily activities like walking and talking over 43 days. Participants must have certain antibod…

This study looks at how the drug bimekizumab affects gene activity in people with moderate to severe plaque psoriasis, with or without psoriatic arthritis. Researchers will take small skin samples to measure changes in gene expression after 48 weeks of treatment. The goal is to b…

This study looks at how much of the drug zilucoplan gets into breast milk. Fifteen healthy women who are already planning to stop breastfeeding will receive daily injections of zilucoplan. Researchers will then measure the drug levels in their milk to estimate how much a nursing …